FTC’s Amgen Activism Will Spare These Biotechs
Wall Street Journal
Federal Trade Commission action to block Amgen-Horizon deal threatens the thesis driving biotech stocks higher.
https://www.wsj.com/articles/ftcs-amgen-activism-will-spare-these-biotechs-310cc702